Authors


Jenna Januszka, PharmD, BCPS, AAHIVP

Latest:

The Art of ART: The Pharmacist’s Role in HIV Care

Pharmacists involvement in HIV care and treatment has been shown to lead to clinically and statistically significant improvements in ART adherence, as well as greater viral load suppression for patients with HIV.


Rose McNulty

Latest:

Differentiating Features of Atypical Hepatocellular Carcinoma vs Intrahepatic Mass-Forming Cholangiocarcinoma in Contrast-Enhanced MRI

Distinguishing between atypical hepatocellular carcinomas and intrahepatic cholangiocarcinoma can be difficult, but researchers identified several reliable MRI features to assist in differentiation.


Christian Ruff, MD, MPH

Latest:

New Data Highlights Abelacimab’s Safety Advantage in Atrial Fibrillation

Christian Ruff, MD, highlights abelacimab’s potential to significantly reduce bleeding in patients with high-risk atrial fibrillation.


David Filstein

Latest:

Outlook for Health System-Based Specialty Pharmacy in 2022 and Beyond

With integrated specialty pharmacies enabling health systems to improve patient outcomes and lower total medical costs, every hospital will need a solution to support the growing number of patients on outpatient specialty medications.


Mark N. Sorial, PharmD, BCOP

Latest:

Bispecific T-Cell–Engaging Antibodies in B-Cell Lymphoma: Efficacy, Safety, and Practical Considerations

This article reviews the efficacy and safety data for bispecific T-cell engagers and the practical considerations for their implementation across various types of practice sites for the historically difficult-to-treat relapsed/refractory B-cell lymphoma population.


Hasina Jalala

Latest:

When It Comes to Curbing Drug Abuse, Technicians Are Crucial

Adequate training will help them recognize signs of misuse and assist with preventive measures.


Tori Erxleben-Rush, PharmD

Latest:

Pharmacy Care Management Can Address the Challenges of an Evolving Health Care Landscape

When pharmacists are involved in the care process, they can address common barriers to medication use, such as polypharmacy, ineffective medication, high costs, health and lifestyle considerations, and social needs.


Stephanie Mason, PharmD, CDCES

Latest:

Pharmacists: Pioneers of Inpatient Medication Safety

Improving patient safety and reducing harmful events is a team effort that includes both executive leadership and management as well as front line care teams.


Aubrey R. Lasko, PharmD, BCOP

Latest:

Targeting DLL3 in Small Cell Lung Cancer and Other Neuroendocrine Carcinomas

DLL3 is an emerging therapeutic target in small cell lung cancer and other neuroendocrine carcinomas, with 1 FDA-approved therapy and several others under investigation.


Bunmi Ikunika, PharmD Candidate

Latest:

A Pharmacist’s Guide to the Management of Polycystic Ovarian Syndrome

Pharmacists play an important role in managing patients with this complex condition.


Varun Choudhary, MD, MA, DFAPA

Latest:

How Pharmacists Can Help Patients With Bipolar Disorder Make Informed Treatment Decisions

Studies suggest bipolar disorder is associated with increased potential for stroke and higher odds of experiencing poor outcomes.


Rada Zunich, PharmD

Latest:

Valerian: Root of All Zzz’s or Just Another Bedtime Story?

Several studies on valerian have been conducted in the past 50 years for indications varying from insomnia, anxiety, restless leg syndrome, headaches, and more.


Andrew T. Ruplin, PharmD

Latest:

Evolving Standards of Care in the Systemic Treatment of Metastatic Urothelial Cancer

Treatment of advanced/metastatic urothelial cancer has changed dramatically in recent years. This review discusses the use, risks, and benefits of several novel therapies for this indication.


Maria Roberts, PharmD

Latest:

Social Determinants of Health Matter When Treating Patients With Breast Cancer

Pharmacists play a critical role in treating patients with breast cancer and can help address their social determinant of health challenges.


Carolyn J. Graziano, DPT, MBA

Latest:

Rising Use of Herbal Supplements Creates Awareness of Risks During the Perioperative Period

Pharmacists can get involved by counseling patients on when to halt use of supplements, as well as proper use and selection of products.


Marlene Wang, MS

Latest:

Clinical Overview: Tildrakizumab-asmn (Ilumya) for Plaque Psoriasis

Tildrakizumab-asmn is a humanized IgG1/k monoclonal anti-IL-23 antibody indicated for the treatment of adults with moderate-to-severe plaque psoriasis.


Daniel Ryabo, PharmD candidate 2025; Ifra Khan, PharmD candidate 2025; Aslan Amirov, PharmD candidate 2025; Mahmoud Shahin, PharmD candidate 2025; Tina Zerilli, PharmD

Latest:

Clinical Overview: Lecanemab Offers Hope for Patients With Alzheimer Disease

Lecanemab is a humanized immunoglobulin gamma 1 monoclonal antibody that targets amyloid plaques, which are thought to play a role in the development and progression of Alzheimer disease.


Arman Melikyan, PharmD Candidate

Latest:

Introducing Obecabtagene Autoleucel: A New Chapter in ALL Treatment

Obecabtagene autoleucel improves CAR T-cell therapy for B-cell ALL.


Sara Panella, PharmD, BCPS

Latest:

Transitions of Care in Patients With Recurrent C. Diff: An Opportunity for Collaboration Among Community, Health System Pharmacists

Approximately 450,000 cases of Clostridioides difficile infection occur each year in the United States and approximately 25% of patients treated for an initial episode will experience recurrence.


Sabiyah Siddiqui

Latest:

Deprescribing Helps Optimize Medication Use

Frequent reassessments of therapy regimens address polypharmacy, particularly for older patients.


Carrie Koenigsfeld, PharmD, FAPhA

Latest:

Vaccination Community Outreach Initiatives

Carrie Koenigsfeld, PharmD, FAPhA, discusses examples of successful community outreach initiatives aimed at overcoming barriers to adult RSV vaccination.



Christopher Burke

Latest:

Building Resilience: Opportunities for US Pharma to Strengthen Public Health in Africa Amid Changing Aid Policies

Africa’s rapidly growing population, expected to reach 2.5 billion by 2050, means an increasing demand for health care and medications.


Michael D. Brown

Latest:

Addressing Ongoing Hospital Pharmacy Staffing Challenges

At a time when pharmacist burnout and turnover is higher than ever before, talent retention is increasingly a strategic imperative for hospitals.


Kaitlyn W. Miller, PharmD, BCOP

Latest:

Clinical Outcomes of Oral Anticancer Regimens in NSCLC Patients Managed in an Integrated Health-System Specialty Pharmacy Program

Pharmacist interactions provide significant benefits for patients with non-small cell lung cancer treated with oral oncolytics.


Nicola Harte, MSc

Latest:

Healing Trust in Medicine in a Fractured Post-Pandemic Landscape

The pandemic’s aftermath left lasting tensions in health care.


Betsy Impreso, CPhT

Latest:

Pharmacy Technicians as Non-Pharmacist Preceptors for a Sterile Compounding Rotation

Recognizing pharmacy technicians as non-pharmacist preceptors can provide an opportunity for professional development while encouraging technicians to practice at the top of their education and training activities.


John Vinson, PharmD

Latest:

Walgreens Doubles Down on Care Team Integration

But the role of the pharmacy chain in health systems, primary care, and specialty is uncertain.


Fenil Patel, NSU College of Pharmacy '23

Latest:

The Benefit of Integrating Residency Workshops Into Pharmacy School Curriculum

In light of the growing numbers of students opting for post-graduate trainings, colleges and schools of pharmacy may want to consider offering electives geared toward exposing students to post-graduate career possibilities and provide guidance toward success.


Rachel Gilmore, PharmD

Latest:

Removing Mesna From Cyclophosphamide Cycles in VAdriaC-IE for Ewing Sarcoma

This retrospective cohort study provides preliminary evidence for safe removal of mesna from VAdriaC cycles, as the incidence of hemorrhagic cystitis did not increase in patients with Ewing sarcoma who received cyclophosphamide without prophylactic mesna.